Artivion to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Artivion, Inc. (NYSE: AORT), a leader in cardiac and vascular surgery, announced its participation in the Oppenheimer 33rd Annual Healthcare Conference.

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT), a leader in cardiac and vascular surgery, announced its participation in the Oppenheimer 33rd Annual Healthcare Conference. The virtual event is set for March 14, 2023, at 3:20 p.m. ET. A live webcast will be available on Artivion's website, with a 90-day archive post-event. Headquartered in Atlanta, Georgia, Artivion specializes in solutions for aortic disease, offering products like aortic stents, surgical sealants, and On-X mechanical heart valves. The company operates in over 100 countries globally. For more information, visit www.artivion.com.

Argus Session date unavailable

-2.76% session move Open Argus

Details

News Market Reaction – AORT

The recorded move for AORT in the trading session of this news was -2.76%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, March 6, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 33^rd Annual Healthcare Conference. The Company's virtual fireside chat is scheduled to begin at 3:20 p.m. ET on March 14, 2023.  

A live webcast of the virtual fireside chat will be accessible through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion          D. Ashley Lee                                                 Executive Vice President and Chief Financial Officer Phone: 770-419-3355	Gilmartin Group LLC Brian Johnston / Lynn Lewis Phone:  332-895-3222 investors@artivion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-oppenheimer-33rd-annual-healthcare-conference-301763779.html

SOURCE Artivion, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date and time of Artivion's virtual fireside chat at the Oppenheimer Healthcare Conference?

Artivion's virtual fireside chat is scheduled for March 14, 2023, at 3:20 p.m. ET.

Where can I watch the Artivion webcast from the Oppenheimer Conference?

The Artivion webcast will be available on their website, specifically on the Investors page.

How long will the Artivion webcast be available after the event?

An archived copy of the Artivion webcast will be available for 90 days.

What products does Artivion, Inc. develop for aortic disease?

Artivion develops aortic stents, stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues.